LSE - Delayed Quote GBp
Oxford Biomedica plc (OXB.L)
300.50
+1.50
+(0.50%)
As of 12:07:42 PM GMT+1. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 22.61M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Briarwood Chase Management L.L.C. -- | -- | Direct | -- | Apr 2, 2025 |
| M & G Investment Management, Ltd. -- | -- | Direct | -- | Feb 19, 2025 |
| Columbia Threadneedle Investments (UK) -- | -- | Direct | -- | Feb 14, 2025 |
| Briarwood Chase Management L.L.C. -- | -- | Direct | -- | Jan 14, 2025 |
| M & G Investment Management, Ltd. -- | -- | Direct | -- | Jan 14, 2025 |
| Columbia Threadneedle Investments (UK) -- | -- | Direct | -- | Oct 30, 2024 |
| Liontrust Asset Management Plc -- | -- | Direct | -- | Oct 29, 2024 |
| BlackRock Advisors (UK) Limited -- | -- | Direct | -- | Oct 1, 2024 |
| BlackRock Advisors (UK) Limited -- | -- | Direct | -- | Sep 30, 2024 |
| Mitrophanous (Kyriacos) -- | -- | Direct | -- | Jul 2, 2024 |
| Mitrophanous (Kyriacos) -- | Sold at price 3.80 per share. | Direct | 7,005 | Jul 2, 2024 |
| BlackRock Advisors (UK) Limited -- | -- | Direct | -- | Jun 27, 2024 |
| Mitrophanous (Kyriacos) -- | -- | Direct | -- | Jun 25, 2024 |
| Mitrophanous (Kyriacos) -- | Sold at price 3.80 per share. | Direct | 1,042 | Jun 25, 2024 |
| Novo Nordisk A/S -- | -- | Direct | -- | Jun 19, 2024 |
| Vitruvian Partners LLP -- | -- | Direct | -- | Jun 19, 2024 |
| Institut Merieux SA -- | -- | Direct | -- | Jun 19, 2024 |
| Hayden (Michael Reuben) -- | -- | Direct | -- | Apr 29, 2024 |
| Henderson (Stuart) -- | -- | Direct | -- | Apr 29, 2024 |
| Davies (Kay) -- | -- | Direct | -- | Apr 29, 2024 |
| Doliveux (Roch Frederic) -- | -- | Direct | -- | Apr 29, 2024 |
| Mathias (Frank) -- | -- | Direct | -- | Apr 29, 2024 |
| Moukheibir (Catherine) -- | -- | Direct | -- | Apr 29, 2024 |
| Patel (Namrata) -- | -- | Direct | -- | Apr 29, 2024 |
| Patterson (Leone D. CPA) -- | -- | Direct | -- | Apr 29, 2024 |
| Paynter (Stuart) -- | -- | Direct | -- | Apr 29, 2024 |
| Preston (Heather Elizabeth) -- | -- | Direct | -- | Apr 29, 2024 |
| Novo Nordisk A/S -- | -- | Direct | -- | Apr 15, 2024 |
| Serum Life Sciences Ltd -- | -- | Direct | -- | Apr 15, 2024 |
| Vitruvian Partners LLP -- | -- | Direct | -- | Apr 15, 2024 |
| Vulpes Life Science Fund -- | -- | Direct | -- | Apr 15, 2024 |
| Liontrust Asset Management Plc -- | -- | Direct | -- | Apr 15, 2024 |
| M & G Investment Management, Ltd. -- | -- | Direct | -- | Apr 15, 2024 |
| Columbia Threadneedle Investments (UK) -- | -- | Direct | -- | Apr 15, 2024 |
| Hargreaves Lansdown Asset Management Ltd. -- | -- | Direct | -- | Apr 15, 2024 |
| Institut Merieux SA -- | -- | Direct | -- | Apr 15, 2024 |
| Lansdowne Partners (UK) LLP -- | -- | Direct | -- | Apr 15, 2024 |
| Institut Merieux SA -- | -- | Direct | -- | Jan 29, 2024 |
| Hargreaves Lansdown Asset Management Ltd. -- | -- | Direct | -- | Dec 31, 2023 |
| Hayden (Michael Reuben) -- | -- | Direct | -- | Dec 31, 2023 |
| Henderson (Stuart) -- | -- | Direct | -- | Dec 31, 2023 |
| Institut Merieux SA -- | -- | Direct | -- | Dec 31, 2023 |
| Columbia Threadneedle Investments (UK) -- | -- | Direct | -- | Dec 31, 2023 |
| Davies (Kay) -- | -- | Direct | -- | Dec 31, 2023 |
| Doliveux (Roch Frederic) -- | -- | Direct | -- | Dec 31, 2023 |
| Fidelity Investments -- | -- | Direct | -- | Dec 31, 2023 |
| Liontrust Asset Management Plc -- | -- | Direct | -- | Dec 31, 2023 |
| M & G Investment Management, Ltd. -- | -- | Direct | -- | Dec 31, 2023 |
| Mathias (Frank) -- | -- | Direct | -- | Dec 31, 2023 |
| Moukheibir (Catherine) -- | -- | Direct | -- | Dec 31, 2023 |
Related Tickers
SCLP.L Scancell Holdings plc
10.72
+2.05%
ONT.L Oxford Nanopore Technologies plc
116.20
-1.44%
19X.SG Axsome Therapeutics Inc
89.86
-2.24%
ONTl.XC
BSFA.L BSF Enterprise Plc
1.3370
-2.76%
96X.F FluoGuide A/S
3.2600
+2.84%
ACE.ST Ascelia Pharma AB (publ)
3.0900
0.00%
PILA.ST Pila Pharma AB (publ)
3.2600
-5.92%
PRTC PureTech Health plc
16.74
+0.66%
TSBX Turnstone Biologics Corp.
0.3300
+0.30%